FDA Inspection 1123377 — CareFusion 303, Inc.

CareFusion 303, Inc. — FEI 2016493

The FDA completed an inspection of CareFusion 303, Inc. on April 6, 2020 in San Diego, CA. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 8 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
April 6, 2020
Fiscal Year
2020
Product Type
Devices
Project Area
Compliance: Devices
Location
San Diego, CA (United States)

Citations

IDCFRDescription
1471321 CFR 820.198(a)Lack of or inadequate complaint procedures
265021 CFR 820.30(f)Design verification - Lack of or inadequate procedures
313021 CFR 820.100(a)Lack of or inadequate procedures
317221 CFR 820.198(c)Investigation of device failures
334521 CFR 820.200(a)Servicing - Lack of or inadequate procedures
367721 CFR 820.30(g)Design validation - software validation not performed
419221 CFR 806.10(a)(2)Report of violation of the Act (see 803.52(e)(9))
63021 CFR 803.17Lack of Written MDR Procedures